Globus Medical Inc (GMED) stock has risen 43.53% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives GMED stock a score of 68 out of a possible 100. That rank is chiefly influenced by a short-term technical score of 94. GMED's rank also includes a long-term technical score of 68. The fundamental score for GMED is 43. In addition to the average rating from Wall Street analysts, GMED stock has a mean target price of $86.09. This means analysts expect the stock to gain 9.56% over the next 12 months.
News Home
Is Globus Medical Inc (GMED) Stock a Attractive Value?
Mentioned in this article
GMED has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on GMED!